Centene — Oct 25, 2024 release

12) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS THIRD QUARTER 2024 RESULTS -- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- • Adjusted diluted EPS of $1.62 in the third quarter of 2024. • Premium and service revenues of $36.9 billion in the third quarter of 2024. • Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023. • Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024. ST. LOUIS, October 25, 2024 -- Centene Corporation (NYSE: CNC) ("the Company") announced today its financial results for the third quarter ended September 30, 2024. In summary, the 2024 third quarter results were as follows: Total revenues (in millions) $ 42,023  Premium and service revenues (in millions) $ 36,899  Health benefits ratio 89.2  % SG&A expense ratio 8.3  % Adjusted SG&A expense ratio (1) 8.3  % GAAP diluted EPS $ 1.36  Adjusted diluted EPS (1) $ 1.62  Total cash flow used in operations (in millions) $ (978) (1) Represents a non-GAAP financial measure. A full reconciliation of the adjusted diluted earnings per share (EPS) and adjusted selling, general and administrative (SG&A)